title: Characteristics of foot fractures in HIV-infected patients previously treated with tenofovir versus non-tenofovir-containing highly active antiretroviral therapy.
abstract: In a retrospective case series study, medical records were evaluated for all male patients infected with human immunodeficiency virus (HIV) diagnosed over a one-year period with foot fractures (n = 30) confirmed by magnetic resonance imaging at a Los Angeles outpatient private practice rheumatology clinic. Proportionally more patients had received tenofovir prefracture (17 [57%]) than those who had not (13 [43%]). At fracture diagnosis, these two groups were similar in median age (49 versus 48 years), HIV-1 RNA (both 1.7 log(10) copies/mL), CD4 count (300 versus 364/mm(3)), time between HIV diagnosis and foot fracture (both 17 years), family history of degenerative bone disease (24% versus 23%), prevalence of malabsorption syndrome, renal failure, calcium deficiency, or vitamin D deficiency, and concurrent use of bisphosphonates, calcitonin, and diuretics. However, more tenofovir-treated patients had osteoporosis (35% versus 8%), stress-type fractures (53% versus 31%), concurrent fractures (12% versus 0%), wasting syndrome (29% versus 15%), truncal obesity (18% versus 8%), smoked cigarettes (more than one pack/day for more than one year; 35% versus 8%), dual energy X-ray absorptiometry (DEXA) T scores < -2.4 (denoting osteoporosis) at the femur (24% versus 9%) and spine (47% versus 36%), and had received protease inhibitors (71% versus 46%), non-nucleoside reverse transcriptase inhibitors (24% versus 0%), prednisone (24% versus 0%), testosterone (47% versus 23%), and teriparatide (29% versus 8%). Median time from tenofovir initiation until fracture was 2.57 (range 1.17-5.69) years. In conclusion, more foot fractures were observed in tenofovir-treated patients than in non-tenofovir-treated patients with HIV infection. Comorbidities and/or coadministered drugs may have been contributory.
authors.affiliation: Center for Rheumatology, Los Angeles, CA, USA.
authors.forename: Arash A
authors.initials: AA
authors.lastname: Horizon
authors.forename: Robert J
authors.initials: RJ
authors.lastname: Joseph
authors.forename: Qiming
authors.initials: Q
authors.lastname: Liao
authors.forename: Steven T
authors.initials: ST
authors.lastname: Ross
authors.forename: Gary E
authors.initials: GE
authors.lastname: Pakes
references.citation: AIDS. 2008 May 31;22(9):1094-7
references.pmid: 18520358
references.citation: AIDS Read. 2007 Jun;17(6):322-8, C3
references.pmid: 17632940
references.citation: AIDS. 2001 Jan 26;15(2):278-80
references.pmid: 11216941
references.citation: AIDS. 2007 Mar 12;21(5):617-23
references.pmid: 17314524
references.citation: AIDS. 2009 Jul 17;23(11):1367-76
references.pmid: 19424051
references.citation: J Orthop Res. 2002 Nov;20(6):1185-9
references.pmid: 12472227
references.citation: J Clin Endocrinol Metab. 2001 May;86(5):2020-6
references.pmid: 11344201
references.citation: HIV Med. 2005 Sep;6(5):341-6
references.pmid: 16156882
references.citation: Bone. 2006 Jun;38(6):893-7
references.pmid: 16377270
references.citation: AIDS. 2001 Apr 13;15(6):807-8
references.pmid: 11371701
references.citation: MedGenMed. 2005 May 09;7(2):3
references.pmid: 16369382
references.citation: Clin Exp Rheumatol. 2009 Nov-Dec;27(6):1001-3
references.pmid: 20149322
references.citation: Br J Radiol. 2005 Jun;78(930):493-8
references.pmid: 15900054
references.citation: Ann Intern Med. 1995 Jan 1;122(1):9-16
references.pmid: 7985914
references.citation: Injury. 2004 Sep;35(9):852-6
references.pmid: 15302236
references.citation: J Clin Endocrinol Metab. 2007 Feb;92(2):497-503
references.pmid: 17077132
references.citation: N Engl J Med. 1997 Sep 4;337(10):670-6
references.pmid: 9278463
references.citation: J Clin Rheumatol. 2009 Mar;15(2):72-4
references.pmid: 19265350
references.citation: AIDS. 2009 Jul 31;23(12):1519-29
references.pmid: 19531929
references.citation: AIDS. 2006 Nov 14;20(17):2165-74
references.pmid: 17086056
references.citation: JAMA. 2004 Jul 14;292(2):191-201
references.pmid: 15249568
references.citation: J Int Assoc Physicians AIDS Care (Chic). 2004 Jul-Sep;3(3):86-91
references.pmid: 15573712
references.citation: Joint Bone Spine. 2002 Oct;69(5):482-5
references.pmid: 12477232
references.citation: J Acquir Immune Defic Syndr Hum Retrovirol. 1999 Apr 1;20(4):323-33
references.pmid: 10096575
references.citation: AIDS. 2009 Jul 17;23(11):1297-310
references.pmid: 19550284
references.citation: J Clin Endocrinol Metab. 1998 Mar;83(3):801-6
references.pmid: 9506731
references.citation: AIDS. 2001 Apr 13;15(6):703-9
references.pmid: 11371684
references.citation: AIDS. 2001 Jan 5;15(1):137-8
references.pmid: 11192861
references.citation: J Infect Dis. 2009 Dec 1;200(11):1746-54
references.pmid: 19874178
references.citation: AIDS. 2000 Mar 10;14(4):F63-7
references.pmid: 10770534
references.citation: J Clin Endocrinol Metab. 2004 Mar;89(3):1200-6
references.pmid: 15001610
references.citation: Rev Esp Med Nucl. 2006 Mar-Apr;25(2):103-6
references.pmid: 16759616
references.citation: AIDS. 2006 Oct 24;20(16):2043-50
references.pmid: 17053350
references.citation: Ann Pharmacother. 2003 Apr;37(4):582-5
references.pmid: 12659619
references.citation: J Assoc Physicians India. 2008 Jun;56:418-24
references.pmid: 18822620
references.citation: Rheum Dis Clin North Am. 2010 Nov;36(4):665-80
references.pmid: 21092845
references.citation: HIV Med. 2009 Sep;10(8):482-7
references.pmid: 19459988
references.citation: Clin Infect Dis. 2009 Nov 15;49(10):1591-601
references.pmid: 19842973